MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0045823
Anum Pharmaceuticals Private Limited
Anum Pharmaceuticals Private Limited - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹25.13 Lakh
▼ 33% YoY
Net profit · FY 2024
₹46,750
Net margin 1.9%
EBITDA · FY 2024
₹62,330
EBITDA margin 2.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Anum Pharmaceuticals Private Limited
Data last updated:
Anum Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 November 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U51909MH2019PTC333668. Its GSTIN is 27AASCA9823C1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ashish Gangadhar Chole and Meher Ambadasji Umale.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot 79 Vp Guihnirman Sanshantha Om Nagar Near Vox Cooler Koradi Road, Nagpur, Maharashtra, India – 440030.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.13 Lakh, a decline of 33% compared to the previous year. For the same year it recorded a net profit of ₹46,750 (net margin 1.9%) and EBITDA of ₹62,330 (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 73% over three years.
Anum Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0045823).
Company details
CIN U51909MH2019PTC333668
Registration Number 333668
Incorporation Date 27 November 2019
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0045823
Recognitions & Rankings of Anum Pharmaceuticals
Contact details
Anum Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot 79 Vp Guihnirman Sanshantha Om Nagar Near Vox Cooler Koradi Road, Nagpur, Maharashtra, India – 440030
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Anum Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anum Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anum Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anum Pharmaceuticals Private Limited, buy the company report.
Financials of Anum Pharmaceuticals Private Limited
FY 2024 filings availableAnum Pharmaceuticals Private Limited reported revenue of ₹25.13 Lakh (down 33% YoY) for FY 2024.
Revenue · FY 2024
₹25.13 Lakh ▼ 33%
Net profit · FY 2024
₹46,750 margin 1.9%
EBITDA · FY 2024
₹62,330 margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 33%
3 years · compounded
▲ 73%
EBITDA CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 48%
Revenue fell 33% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 73%. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹62,330 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹46,750 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anum Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anum Pharmaceuticals Private Limited
Anum Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashish Gangadhar Chole | Director | 27 Nov 2019 | 6 Years 10 Months | Current |
| Meher Ambadasji Umale | Director | 27 Nov 2019 | 6 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Anum Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anum Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anum Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AASCA9823C1ZF | Maharashtra | Active | 25 Mar 2020 |
To see the full GST registrations and return filing status of Anum Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anum Pharmaceuticals Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Durvesh Pankule ceased to be Director on 13 Nov 2020.
AGM
Anum Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Anum Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Nagpur.
Ceased
Durvesh Pankule ceased to be Director.
Appointed
Ashish Gangadhar Chole was appointed as Director.
Appointed
Meher Ambadasji Umale was appointed as Director.
Incorporation
27 Nov 2019
Anum Pharmaceuticals Private Limited was registered on 27 Nov 2019 with Roc Nagpur & aged 6 years 10 months as per MCA records.
Frequently asked questions
Anum Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 November 2019 (7+ years old) and is registered under CIN U51909MH2019PTC333668.
Anum Pharmaceuticals has 2 current directors:
- Ashish Gangadhar Chole - Director
- Meher Ambadasji Umale - Director
The latest financial statements of Anum Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Anum Pharmaceuticals is 27AASCA9823C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Anum Pharmaceuticals is U51909MH2019PTC333668. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anum Pharmaceuticals was incorporated on 27 November 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
Durvesh Pankule ceased to be Director on 13 Nov 2020. Ashish Gangadhar Chole was appointed as Director on 27 Nov 2019. Meher Ambadasji Umale was appointed as Director on 27 Nov 2019.
Yes, Anum Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0045823).
The registered office of Anum Pharmaceuticals is at Plot 79 Vp Guihnirman Sanshantha Om Nagar Near Vox Cooler Koradi Road, Nagpur, Maharashtra, India – 440030.
Anum Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.